Clinical Scorecard: Utilizing Optical Coherence Tomography Angiography and Optical Coherence Tomography for the Prediction of Polyvascular Disease
At a Glance
Category
Detail
Condition
Polyvascular disease (PVD), defined as atherosclerosis involving two or more vascular beds
Key Mechanisms
Microvascular dysfunction precedes macrovascular events; retinal microvascular alterations reflect systemic endothelial health; high-risk coronary plaque features detectable by OCT/IVUS
Target Population
Patients with acute coronary syndrome (ACS) undergoing coronary angiography
Care Setting
Cardiology and vascular imaging centers with access to OCT, IVUS, OCTA, and NCE-MRA
Key Highlights
PVD is associated with substantially higher cardiovascular mortality and morbidity and is frequently underdiagnosed and undertreated.
Retinal microvascular changes detected by OCTA and coronary plaque characteristics by OCT/IVUS may serve as markers for PVD in ACS patients.
Non-contrast enhanced magnetic resonance angiography (NCE-MRA) is used to identify PVD by detecting ≥ 50% stenosis in intracranial, carotid, and renal arteries.
Guideline-Based Recommendations
Diagnosis
Use NCE-MRA to screen for PVD in intracranial, carotid, and renal arteries with stenosis ≥ 50% as diagnostic criteria.
Employ OCTA to assess retinal microvascular alterations as potential indicators of systemic microvascular dysfunction.
Utilize OCT/IVUS imaging to characterize high-risk coronary plaques in ACS patients.
Management
Adopt holistic management strategies addressing shared risk factors between CAD and PVD to optimize patient outcomes.
Consider early identification of microvascular dysfunction to guide risk stratification and treatment planning.
Monitoring & Follow-up
Perform quality-controlled OCTA imaging with AI-assisted segmentation for longitudinal assessment of retinal microvascular parameters.
Use serial OCT/IVUS imaging to monitor coronary plaque characteristics and progression.
Risks
Underdiagnosis and undertreatment of PVD may lead to increased cardiovascular morbidity and mortality.
Poor image quality and technical limitations can affect diagnostic accuracy of OCT, IVUS, and OCTA.
Patient & Prescribing Data
Acute coronary syndrome patients undergoing coronary angiography and vascular imaging
Identification of PVD via multimodal imaging may inform intensified cardiovascular risk management but specific pharmacologic treatment data are not provided.
Clinical Best Practices
Ensure high-quality imaging acquisition and rigorous quality control for OCT, IVUS, OCTA, and NCE-MRA to maximize diagnostic yield.
Use blinded independent analysts and consensus readings to improve reliability of vascular stenosis assessments.
Incorporate AI algorithms for automated retinal/choroidal boundary detection and quantitative analysis in OCTA imaging.
Select clinically representative imaging parameters to avoid multicollinearity in predictive modeling.
Integrate multimodal imaging findings to enhance early detection and risk stratification of PVD in ACS patients.
